Equities
Evonik shares jump 4.8% on BASF merger talk reports
Evonik stock rose nearly 5% after media cited Dealreporter and Mergermarket reports of BASF discussions on a possible transaction, while the firm continues its restructuring plan.
Valion Bio regains Nasdaq $1 bid price compliance
Valion Bio received written notice from Nasdaq confirming it met the $1 minimum bid price requirement after its shares closed at $2.38, up 12.26%, on Sep 21.
Enlivex Ends $200M+ Private Placement After Rain Foundation Deal Termination
Enlivex Ltd. (ENLV) halted a planned $66.7M share sale to Rain Foundation, citing shareholder approval failure and exercising termination rights under the agreement.
Scynexis Names Former Akebia Chief Medical Officer to Its Board
The clinical-stage biotech has added Steven K. Burke, currently SVP and chief research and development officer at Akebia Therapeutics, to its board of directors effective Sept. 18.
PDS Biotech Reports 39.3-Month Median Survival in HPV16 Head-and-Neck Cancer Trial
The Phase 2 VERSATILE-002 study showed a median overall survival of 39.3 months for patients with HPV16-positive recurrent or metastatic head and neck squamous cell carcinoma who were naïve to checkpoint inhibitors and had PD-L1 CPS ≥1. The combination of PDS0101 and pembrolizumab yielded an objective response rate of 36% with a manageable safety profile.
Electra AI signs multiple commercial deals ahead of Nasdaq listing
Electra AI, valued at about $250 million, announced a series of partnerships with D‑Orbit, Naoris Quantum, Propel Industries, Omega Seiki, MinTech and Mooving as it prepares for a Nasdaq debut via a SPAC merger with Iron Horse Acquisition II.
CNSide Diagnostics signs in‑network agreement with Blue Cross Blue Shield of Michigan
CNSide Diagnostics, a Cerenome subsidiary, will provide its CSF tumor cell assay to Blue Cross Blue Shield of Michigan, expanding coverage to about 158 million lives.
US-Märkte vor Eröffnung ohne klare Richtung: SMI gedämpft, UBS unter Druck
Schweizer Aktienindex leidet unter globaler Unsicherheit; UBS fällt unter Regulierungsfragen, während On-Aktien durch Wachstumsprognosen und Rückkaufprogramm unterstützt werden.
Beta Bionics and Senseonics Partner on Glucose Monitoring Integration
Beta Bionics Inc. and Senseonics have partnered to integrate their automated insulin delivery systems with the Eversense 365 continuous glucose monitoring system, expected to launch in Q4 2026.
Greenbrier Secures $600M Railcar Order from Saudi Railway
The Greenbrier Companies secured 3,400 railcar orders valued at $600 million, including a significant Saudi Railway deal for tank cars and intermodal units.
Borsa Istanbul to drop over a quarter of BIST-100 constituents
More than 25% of the stocks currently in Turkey's BIST-100 benchmark will be removed next month as the exchange tightens eligibility rules, without citing a specific trigger.
CollPlant Regains Nasdaq Compliance After Share Price Dips Below $1
The Rehovot-based biotech firm restored its Nasdaq listing after its shares closed at or above the $1 minimum for 10 consecutive business days.
Arrive AI to Showcase Autonomous Delivery Tech at Investor Event
The Indiana-based logistics firm will demonstrate its Arrive Point network, AMR handoff system, and simulated drone deliveries during a virtual investor event Wednesday.
Wave Life Sciences appoints Monika Vnuk as chief business officer
Wave Life Sciences has appointed Monika Vnuk to the role of chief business officer.
Lantern Pharma Secures Patent for LP-284 Cancer Drug
USPTO grants Notice of Allowance for LP-284, targeting mantle cell lymphoma and double-hit lymphoma, with broader claims covering combination therapies and a 2042 patent expiry.
Alibaba, Quest Diagnostics, On Holding, GameStop Lead Premarket Moves
Shares of Alibaba, Quest Diagnostics, On Holding and GameStop are among the standout movers ahead of the opening bell on Tuesday.
IDEAYA Biosciences Shares Drop Amid 2026 Pipeline Updates at Citigroup Summit
IDEAYA Biosciences reported progress on its oncology pipeline, including regulatory milestones for Darovasertib and IDE849, amid a market cap of $3.66 billion and a 55% year-to-date return.
ProMIS Neurosciences presents interim Alzheimer's data at Moody Capital; shares climb
ProMIS reported zero ARIA-E and a 15% p-tau217 drop in its PMN310 interim safety analysis at the Moody Capital conference, sending shares up nearly 8%.
Arm Holdings Surges 17% on 'Off-the-Charts' AI Chip Demand
Semiconductor architect reports 22.8% revenue growth and targets $2 billion in AGI CPU business as AI-driven chip demand accelerates.
Santacruz Silver Completes $14M Bolivia Mill Acquisition
Santacruz Silver Mining has completed its acquisition of a 500-tonne-per-day milling facility in Bolivia, adding processing capacity near its Reserva mine.
GoldQuest Mining appoints Martin Wafforn to board of directors
GoldQuest Mining announced the appointment of Martin Wafforn to its board of directors.
iShares to Wind Down iBonds Dec 2026 Corp ETF
BlackRock's fixed-income ETF will cease trading Dec. 23 and redeem all shares compulsorily, with payments expected Jan. 7, 2027.
Playtech raises €350m via senior secured notes due 2031
The gaming technology firm secured a €350 million bond offering as it expands financing ahead of global expansion plans.
Merck’s Winrevair gains FDA approval with 76% risk reduction in PAH clinical trial
Updated labeling reflects Phase 3 HYPERION trial showing 76% lower risk of worsening events for newly diagnosed pulmonary arterial hypertension patients on sotatercept-csrk.